Published in Bioorg Med Chem Lett on September 18, 2013
Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci (2003) 2.85
Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology (2008) 2.49
VEGA--an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. J Comput Aided Mol Des (2004) 2.41
VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model (2002) 2.25
Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci (2002) 2.17
Cytosolic pH is a second messenger for glucose and regulates the PKA pathway through V-ATPase. EMBO J (2010) 1.76
Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release. J Neurosci (2009) 1.76
Life in the midst of scarcity: adaptations to nutrient availability in Saccharomyces cerevisiae. Curr Genet (2010) 1.65
Exploring the activation mechanism of TRPM8 channel by targeted MD simulations. Biochem Biophys Res Commun (2011) 1.49
Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals. Eur J Clin Pharmacol (2008) 1.46
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization. Mol Pharmacol (2008) 1.24
Actin Cys374 as a nucleophilic target of alpha,beta-unsaturated aldehydes. Free Radic Biol Med (2006) 1.18
alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur J Neurosci (2009) 1.10
Regulation of neuronal nicotinic receptor traffic and expression. Brain Res Rev (2007) 1.08
Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. Biochemistry (2007) 1.08
Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience. Mol Pharmacol (2004) 1.07
Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA. Mol Pharmacol (2004) 1.05
Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through α4/β2/α5 nicotinic acetylcholine receptors. Neuropsychopharmacology (2010) 1.04
Molecular dynamics studies of the full-length integrase-DNA complex. Biochem Biophys Res Commun (2005) 1.03
Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? Chem Res Toxicol (2008) 1.03
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. Mol Pharmacol (2010) 1.03
Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures. Brain Res Mol Brain Res (2002) 1.01
Protein carbonylation: 2,4-dinitrophenylhydrazine reacts with both aldehydes/ketones and sulfenic acids. Free Radic Biol Med (2009) 1.00
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors. Biochem Pharmacol (2013) 0.99
Perception of soft mechanical stress in Arabidopsis leaves activates disease resistance. BMC Plant Biol (2013) 0.98
A permeable cuticle is associated with the release of reactive oxygen species and induction of innate immunity. PLoS Pathog (2011) 0.98
Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes. Bioorg Med Chem Lett (2008) 0.97
Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI-MS/MS evidence for Cys374 Michael adduction. J Mass Spectrom (2005) 0.96
WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?). J Med Chem (2006) 0.95
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats. J Cell Mol Med (2010) 0.95
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking. Biochem Biophys Res Commun (2003) 0.92
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists. Br J Pharmacol (2011) 0.92
Comparative modeling of the quaternary structure for the human TRPM8 channel and analysis of its binding features. Biochim Biophys Acta (2009) 0.92
Nicotine-modulated subunit stoichiometry affects stability and trafficking of α3β4 nicotinic receptor. J Neurosci (2013) 0.91
Reactions and enzymes in the metabolism of drugs and other xenobiotics. Drug Discov Today (2012) 0.90
High sensitivity protein assays on microarray silicon slides. Anal Chem (2009) 0.90
Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping. ChemMedChem (2008) 0.88
Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum. J Proteomics (2012) 0.87
Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective α1B-adrenoceptor antagonist. Eur J Med Chem (2012) 0.87
Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors. FASEB J (2011) 0.86
Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS. J Neuroimmunol (2011) 0.86
Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis. Hum Mol Genet (2009) 0.86
An EGOcentric view of TORC1 signaling. Cell Cycle (2010) 0.86
Calcium channel antagonists discovered by a multidisciplinary approach. J Med Chem (2006) 0.85
Visual acuity is reduced in alpha 7 nicotinic receptor knockout mice. Invest Ophthalmol Vis Sci (2012) 0.85
Nicotinic acetylcholine receptor subtypes in the rat sympathetic ganglion: pharmacological characterization, subcellular distribution and effect of pre- and postganglionic nerve crush. J Neuropathol Exp Neurol (2004) 0.85
Fgr deficiency results in defective eosinophil recruitment to the lung during allergic airway inflammation. J Immunol (2002) 0.85
Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products. Free Radic Res (2013) 0.85
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency. Bioorg Med Chem Lett (2007) 0.85
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure. J Med Chem (2007) 0.84
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold. Br J Pharmacol (2013) 0.83
Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex. FASEB J (2012) 0.83
Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets. Biochem J (2006) 0.83
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Br J Pharmacol (2005) 0.82
Edaravone inhibits protein carbonylation by a direct carbonyl-scavenging mechanism: focus on reactivity, selectivity, and reaction mechanisms. Antioxid Redox Signal (2010) 0.82
The proto-oncogene Fgr regulates cell migration and this requires its plasma membrane localization. Exp Cell Res (2005) 0.82
Homology modelling of human DHCR24 (seladin-1) and analysis of its binding properties through molecular docking and dynamics simulations. Steroids (2008) 0.82
1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists. J Med Chem (2012) 0.81
Structure of neuronal nicotinic receptors. Curr Top Behav Neurosci (2015) 0.81
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation. Br J Pharmacol (2013) 0.81
Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146. J Am Chem Soc (2010) 0.81
Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes. Eur J Pharmacol (2003) 0.81
Muscarinic receptors: A comparative analysis of structural features and binding modes through homology modelling and molecular docking. Chem Biodivers (2006) 0.80
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. J Med Chem (2002) 0.80
The direct stimulation of Gi proteins by neuropeptide Y (NPY) in the rat left ventricle. Biochem Pharmacol (2002) 0.80
New synthesis of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid and evaluation of the influence of adamantyl group on the DNA binding of a naphthoic retinoid. Bioorg Chem (2011) 0.80
Extremely low-frequency electromagnetic field (ELF-EMF) does not affect the expression of alpha3, alpha5 and alpha7 nicotinic receptor subunit genes in SH-SY5Y neuroblastoma cell line. Toxicol Lett (2006) 0.80
Alpha7 but not alpha4 AChR subunit expression is regulated by light in developing primary visual cortex. J Comp Neurol (2004) 0.80
Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis. J Med Chem (2006) 0.80
Exploring the space of histidine containing dipeptides in search of novel efficient RCS sequestering agents. Eur J Med Chem (2013) 0.80
Binary polymeric blends to microencapsulate nitroflurbiprofen: physicochemical and in silico studies. Eur J Pharm Sci (2007) 0.80
An investigation into the influence of counterion on the RS-propranolol and S-propranolol skin permeability. J Pharm Sci (2010) 0.80
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase. Bioorg Med Chem Lett (2011) 0.80
The approach of conformational chimeras to model the role of proline-containing helices on GPCR mobility: the fertile case of Cys-LTR1. ChemMedChem (2011) 0.80
Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies. Bioorg Med Chem Lett (2009) 0.80
Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes. J Med Chem (2009) 0.79
Chiral mercaptoacetamides display enantioselective inhibition of histone deacetylase 6 and exhibit neuroprotection in cortical neuron models of oxidative stress. ChemMedChem (2012) 0.79
Ultrathin spin-coated dioleoylphosphatidylcholine lipid layers in dry conditions: a combined atomic force microscopy and nanomechanical study. Langmuir (2011) 0.79
Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha 1 antagonist WB-4101. Bioorg Med Chem (2004) 0.79
QSAR study for a novel series of ortho monosubstituted phenoxy analogues of alpha1-adrenoceptor antagonist WB4101. Bioorg Med Chem (2005) 0.79
Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity. Arch Pharm (Weinheim) (2009) 0.79
Synthesis and alpha4beta2 nicotinic affinity of 2-pyrrolidinylmethoxyimines and prolinal oxime ethers. Bioorg Med Chem Lett (2004) 0.79
Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability. ChemMedChem (2011) 0.79
Predicting the physicochemical profile of diastereoisomeric histidine-containing dipeptides by property space analysis. Chirality (2012) 0.79